Medical Devices and AI: A New Era for Mediana
Mediana is pushing forward in the medical AI market—a strategy that aligns with their aim of becoming akin to Philips in the medical device sector. This move focuses on expanding beyond hardware into AI-based medical solutions and services.
Mediana and Selvas AI Merger Overview
In January last year, Selvas AI acquired Mediana for approximately 732 billion won. This acquisition, deemed ambitious within the domestic medical device sector, was expected to create synergy due to the combination of a software-focused company with a hardware manufacturer.
What This Means for Mediana:
- Mediana’s expertise lies heavily in emergency medical device manufacturing.
- Their patient monitoring devices and automated external defibrillators are well-regarded globally.
- About 68.7% of Mediana’s revenue in the last year came from international markets.
The Role of AI in Mediana’s Growth Strategy
The Combined Strengths:
Selvas AI’s medical voice transcription software, Selvy Medivox, has already captured a market presence. The merger allows for a seamless combination of AI with Mediana’s existing hardware, enhancing functionality and connectivity.
- Connectivity: Presenting a unified front, Selvas AI’s subsidiaries, including Mediana, are focusing on ‘connectivity’.
- Efficiency: By integrating patient monitoring devices with hospital systems, they aim to boost operational efficiency.
- AI Solutions: Leveraging live patient data through AI models, they foresee an enhanced ability to predict patient conditions.
Focus Areas:
- Predictive Medicine: Utilizing real-time signals from monitoring devices rather than relying solely on electronic medical records.
- Remote Solutions: Developing systems like MD RMS for handling emergencies from ambulance to ER.
Challenges and Aspirations
Mediana aims to compete with industry giants like Philips by effectively leveraging medical data from monitoring devices to develop AI solutions for:
- Remote Monitoring and Diagnosis
- AI-driven Predictions and Diagnoses
- Advanced Clinical Services
Business Approach:
- Development of AI-based monitoring and remote consultation systems.
- Creation of new predictive AI solutions by collaborating with other medical AI companies.
- Expanding their market presence and solutions’ reach internationally.
Concluding thoughts
Mediana’s leadership remains optimistic about integrating AI to elevate their position in the global medical device market. Focusing on data-driven innovation, Mediana is poised to transform how medical solutions develop and reach patients worldwide, pushing the capabilities of medical technology into new territories.
Table of Contents
- Introduction
- Mediana’s AI Strategy and Market Expansion
- Vision to Compete with Industry Giants
- Mediana and Selvas AI Merger Overview
- Acquisition Details
- Expected Synergies Between Software and Hardware
- What This Means for Mediana
- Strength in Emergency Medical Devices
- Global Market Presence and Revenue Breakdown
- The Role of AI in Mediana’s Growth Strategy
- Combined Strengths
- Selvas AI’s Medical Voice Transcription Technology
- AI Integration with Mediana’s Hardware
- Key Benefits
- Connectivity and Efficiency Gains
- AI Solutions for Predicting Patient Conditions
- Combined Strengths
- Focus Areas of AI Development
- Predictive Medicine
- Real-Time Patient Monitoring Over Traditional Medical Records
- Remote Solutions
- MD RMS System for Emergency Response and Remote Care
- Predictive Medicine
- Challenges and Aspirations
- Competing with Philips and Other Market Leaders
- Leveraging Medical Data for AI Innovations
- Business Approach and Expansion Plans
- AI-Based Monitoring and Remote Consultation
- Collaborations with Medical AI Companies
- Global Market Penetration Strategies
- Conclusion
- Mediana’s Vision for AI-Driven Healthcare
- The Future of AI and Medical Device Integration



![[South Korea] HUONS Meditech’s URO-UEMXD Expands Global Influence](https://i0.wp.com/productadvisor.com/wp-content/uploads/2024/10/huons-1.png?fit=800%2C616&ssl=1)